Schedule 13D ownership disclosure
PASSAGE BIO INC
Security class unavailable · CUSIP: 702712100
Event date: 2024-04-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 8,034,000
- Percent of class
- 13.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-24-000373
- Form type
- SC 13D
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- Apr 12, 2024
- Reporting period
- Apr 09, 2024
- Description
- Schedule 13D beneficial ownership